VTGN financials

Vistagen Therapeutics (VTGN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

VTGN income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2026$1.27M–-$72.13M-$69.69M-1.83
2025$486.00K–-$55.97M-$51.42M-1.67
2024$1.06M–-$33.02M-$29.36M-1.52
2023––-$59.27M-$59.25M-8.51
2022$1.11M–-$47.78M-$48.71M-7.38
2021$1.09M–-$17.93M-$42.32M-0.49